Private Trust Co. NA Has $382,000 Stake in Monsanto Company (NYSE:MON)

Private Trust Co. NA reduced its position in shares of Monsanto Company (NYSE:MON) by 6.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,229 shares of the basic materials company’s stock after selling 240 shares during the period. Private Trust Co. NA’s holdings in Monsanto were worth $382,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. Delta Asset Management LLC TN raised its stake in Monsanto by 0.5% in the first quarter. Delta Asset Management LLC TN now owns 1,950 shares of the basic materials company’s stock worth $221,000 after buying an additional 10 shares in the last quarter. Savant Capital LLC raised its stake in Monsanto by 0.4% in the first quarter. Savant Capital LLC now owns 3,082 shares of the basic materials company’s stock worth $349,000 after buying an additional 11 shares in the last quarter. Guardian Life Insurance Co. of America raised its stake in Monsanto by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,689 shares of the basic materials company’s stock worth $191,000 after buying an additional 11 shares in the last quarter. Greenwich Wealth Management LLC raised its stake in Monsanto by 0.6% in the first quarter. Greenwich Wealth Management LLC now owns 2,565 shares of the basic materials company’s stock worth $290,000 after buying an additional 15 shares in the last quarter. Finally, Dubuque Bank & Trust Co. raised its stake in Monsanto by 0.7% in the first quarter. Dubuque Bank & Trust Co. now owns 3,425 shares of the basic materials company’s stock worth $388,000 after buying an additional 25 shares in the last quarter. 75.28% of the stock is currently owned by institutional investors.

Monsanto Company (MON) traded down 0.13% during trading on Friday, hitting $116.95. The stock had a trading volume of 1,337,839 shares. Monsanto Company has a 1-year low of $97.35 and a 1-year high of $118.97. The firm’s 50-day moving average price is $117.42 and its 200-day moving average price is $115.30. The stock has a market cap of $51.38 billion, a PE ratio of 25.26 and a beta of 1.07.

Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.19. The business had revenue of $4.23 billion during the quarter, compared to analyst estimates of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The company’s revenue was up 1.0% compared to the same quarter last year. During the same period last year, the company posted $2.17 EPS. On average, equities research analysts predict that Monsanto Company will post $4.89 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be issued a $0.54 dividend. The ex-dividend date is Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.84%. Monsanto’s payout ratio is currently 46.75%.

ILLEGAL ACTIVITY WARNING: This story was first posted by [[site]] and is owned by of [[site]]. If you are viewing this story on another website, it was copied illegally and reposted in violation of U.S. and international copyright law. The original version of this story can be read at [[permalink]].

Several equities research analysts have recently weighed in on MON shares. Zacks Investment Research raised Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price on the stock in a research report on Friday, June 16th. Vetr raised Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price on the stock in a research report on Wednesday, July 12th. UBS AG downgraded Monsanto from a “buy” rating to a “neutral” rating in a research note on Friday. BidaskClub downgraded Monsanto from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Finally, Royal Bank Of Canada restated a “sector perform” rating and set a $128.00 price target (up previously from $120.00) on shares of Monsanto in a research note on Thursday, June 29th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $123.15.

In other news, EVP Robert T. Fraley sold 52,410 shares of the stock in a transaction on Monday, July 10th. The stock was sold at an average price of $117.95, for a total value of $6,181,759.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Steven Mizell sold 11,300 shares of the stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $118.57, for a total value of $1,339,841.00. Following the completion of the sale, the executive vice president now owns 55,011 shares of the company’s stock, valued at approximately $6,522,654.27. The disclosure for this sale can be found here. Insiders sold 74,470 shares of company stock valued at $8,791,281 in the last 90 days. Corporate insiders own 0.79% of the company’s stock.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.